Chemotherapy parity laws: a remedy for high drug costs?

JAMA Intern Med. 2014 Nov;174(11):1721-2. doi: 10.1001/jamainternmed.2014.4878.

Authors

Bo Wang¹, Steven Joffe², Aaron S Kesselheim¹

Affiliations

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Department of Medical Ethics and Health Policy at the Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 25243936
DOI: 10.1001/jamainternmed.2014.4878

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Administration, Intravenous
Administration, Oral
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / economics*
Cost Allocation
Cost Sharing
Drug Costs*
Humans

Substances

Antineoplastic Agents